Side-by-side comparison of AI visibility scores, market position, and capabilities
Houston diversified energy (NYSE: PSX) at $145.5B 2024 revenue; Coastal Bend NGL acquisition $2.2B (2024), Rodeo renewable diesel/SAF complex, LA Refinery closed, Q4 2024 adjusted loss amid refining margin pressure vs Valero.
Phillips 66 is a Houston, Texas-based diversified energy manufacturing and logistics company — publicly traded on the New York Stock Exchange (NYSE: PSX) as an S&P 500 Energy component — operating 13 refineries with 2.2 million barrels-per-day capacity, midstream pipeline and NGL infrastructure, retail fuel brands, a chemicals joint venture, and a renewable fuels facility through approximately 14,000 employees. In fiscal year 2024, Phillips 66 generated $145.5 billion in revenue, though Q4 2024 earnings fell to $8 million versus $346 million in Q3 2024 (adjusted loss of $61 million) due to refining margin compression from the spread between crude oil input costs and refined product prices. Spun off from ConocoPhillips in May 2012, Phillips 66 operates through five segments: Refining (processing crude oil into gasoline, distillates, and aviation fuel), Midstream (crude and NGL pipelines, terminals, and natural gas processing including the 2024 $2.2 billion EPIC NGL acquisition renamed Coastal Bend), Marketing and Specialties (Phillips 66, Conoco, 76, and JET fuel brands at 7,000+ branded retail sites across North America and Europe), Chemicals (CPChem joint venture with Chevron Phillips Chemical producing ethylene, polyethylene, and aromatics), and Renewable Fuels (Rodeo Renewable Energy Complex producing renewable diesel and sustainable aviation fuel — SAF). In 2024, Phillips 66 divested its 65% stake in German and Austrian retail operations for $1.6 billion and announced closure of its Los Angeles Refinery.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.